About Us
About SYNCELL
SYNCELL’s founder and CEO, Jung-Chi Liao PhD, has been developing what is now the Microscoop™ technology at his Academia Sinica laboratory since 2014, after leaving his faculty post at the Columbia University to return to his motherland, Taiwan. Today, SYNCELL’s Microscoop spatial proteomics technology can turn a microscope into a “Microscoop” - the world’s first in-cell “pickable” microscope that applies an AI algorithm to selectively recover proteins and nucleic acids from a specified subcellular location. SYNCELL is excited to provide researchers its novel tool to advance the field of proteomics and play a role in solving some of the world’s most complex biology and disease problems.

SYNCELL was officially spun off from Academia Sinica in 2020 and continues to build and expand its dynamic and diverse team to productize and commercialize the Microscoop technology platform. The company is building a growth culture that is reflective of a founding team with roots in both Silicon Valley and Taiwan, where the core values include being technology-forward, entrepreneurial, curious, risk-taking, and inventive. Having worked in the academic and startup ecosystem of MIT, UC Berkeley, Stanford University and Columbia University, Dr. Liao aims to create a work culture that can invigorate the SYNCELL team to build a successful global company while staying true to its founding team’s passions and drive for excellence.
Our Mission
Our mission is to accelerate the world’s understanding of proteomics.
We continue to expand our multidisciplinary team with dedicated members who strive on pushing the technology boundary to create the first and only de novo precision spatial proteomics tool. SYNCELL will soon bring its innovation to market as products and services to empower researchers to address previously unattainable complex biological problems and revolutionize the proteomics field.
  • SYNCELL won the 17th National Innovation Award of Taiwan in the Specialized Materials and Applied Biotechnology category in 2020.
  • SYNCELL was selected as one of the 24 finalists at the Digital RESI in September 2020 from more than 400 presenting startups.
  • SYNCELL was named Company-to-Watch Top 10 finalists at the Bio Investor Forum Digital in October 2020 from more than 130 presenting companies.
  • SYNCELL founder,Jung-Chi Liao, PhD received the 2020 Taiwan Ministry of Science and Technology (MOST) Outstanding Research Award in the field of Physics.
  • SYNCELL was shortlisted on The Scientist Top 10 Innovations in 2020.
“As a cilia biologist, I had always wanted a tool that could isolate morphology-specific or specific protein-enriched primary cilia inside cells to understand their unique proteome. This was the genesis of SYNCELL Microscoop™. This novel system will broadly benefit the cell and tissue biology fields and stimulate the development of the quickly growing field of spatial proteomics research.”
Jung-Chi Liao, PhD
Founder & CEO
About Us
About SYNCELL
SYNCELL’s founder and CEO, Jung-Chi Liao PhD, has been developing what is now the Microscoop™ technology at his Academia Sinica laboratory since 2014, after leaving his faculty post at the Columbia University to return to his motherland, Taiwan. Today, SYNCELL’s Microscoop spatial proteomics technology can turn a microscope into a “Microscoop” - the world’s first in-cell “pickable” microscope that applies an AI algorithm to selectively recover proteins and nucleic acids from a specified subcellular location. SYNCELL is excited to provide researchers its novel tool to advance the field of proteomics and play a role in solving some of the world’s most complex biology and disease problems.

SYNCELL was officially spun off from Academia Sinica in 2020 and continues to build and expand its dynamic and diverse team to productize and commercialize the Microscoop technology platform. The company is building a growth culture that is reflective of a founding team with roots in both Silicon Valley and Taiwan, where the core values include being technology-forward, entrepreneurial, curious, risk-taking, and inventive. Having worked in the academic and startup ecosystem of MIT, UC Berkeley, Stanford University and Columbia University, Dr. Liao aims to create a work culture that can invigorate the SYNCELL team to build a successful global company while staying true to its founding team’s passions and drive for excellence.
Our Mission
Our mission is to accelerate the world’s understanding of proteomics.
We continue to expand our multidisciplinary team with dedicated members who strive on pushing the technology boundary to create the first and only de novo precision spatial proteomics tool. SYNCELL will soon bring its innovation to market as products and services to empower researchers to address previously unattainable complex biological problems and revolutionize the proteomics field.
“As a cilia biologist, I had always wanted a tool that could isolate morphology-specific or specific protein-enriched primary cilia inside cells to understand their unique proteome. This was the genesis of SYNCELL Microscoop™. This novel system will broadly benefit the cell and tissue biology fields and stimulate the development of the quickly growing field of spatial proteomics research.”
Jung-Chi Liao, PhD
Founder & CEO